2-Propen-1-one,1-(4-morpholinyl)-3-phenyl-

Suppliers

Names

[ CAS No. ]:
16619-19-5

[ Name ]:
2-Propen-1-one,1-(4-morpholinyl)-3-phenyl-

[Synonym ]:
4-(3-Phenylacryloyl)morpholine
3-Phenyl-1-morpholino-2-propene-1-one
N-morpholino cinnamide
(E)-1-morpholino-3-phenylprop-2-en-1-one
(E)-1-morpholin-4-yl-3-phenylpropenone
N-cinnamoylmorpholine
(E)-1-morpholin-4-yl-3-phenylprop-2-en-1-one
4-(1-Oxo-3-phenyl-2-propenyl)morpholine
morpholine cinnamide
1-Morpholino-3-phenyl-2-propene-1-one
1-morpholin-4-yl-3-phenyl-propenone

Chemical & Physical Properties

[ Density]:
1.151g/cm3

[ Boiling Point ]:
419.3ºC at 760mmHg

[ Molecular Formula ]:
C13H15NO2

[ Molecular Weight ]:
217.26400

[ Flash Point ]:
207.4ºC

[ Exact Mass ]:
217.11000

[ PSA ]:
29.54000

[ LogP ]:
1.49650

[ Vapour Pressure ]:
3.07E-07mmHg at 25°C

[ Index of Refraction ]:
1.589

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QE0510000
CHEMICAL NAME :
Morpholine, 4-cinnamoyl-
CAS REGISTRY NUMBER :
16619-19-5
LAST UPDATED :
199206
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C13-H15-N-O2
MOLECULAR WEIGHT :
217.29
WISWESSER LINE NOTATION :
T6N DOTJ AV1U1R

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
75 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CSLNX* U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) Volume(issue)/page/year: NX#09248

Safety Information

[ HS Code ]:
2934999090

Precursor & DownStream

Precursor

DownStream

  • Cinnamic aldehyde
  • Methanone,phenyl[(1R,2R)-2-phenylcyclopropyl]-, rel-
  • 1,4-diphenylbut-3-en-2-one

Customs

[ HS Code ]: 2934999090

[ Summary ]:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Related Compounds

  • 2-Propen-1-one, 1-(4-morpholinyl)-3-[5-(3-nitrophenyl)-2-furanyl]-, (2E)
  • 2-Propen-1-one,1-(4-methoxyphenyl)-3-phenyl-
  • 2-Propen-1-one, 1- (4-fluorophenyl)-3-phenyl-
  • 2-Propen-1-one,1-(4-hydroxyphenyl)-3-phenyl-, (2E)-
  • 2-Propen-1-one,1-(4-aminophenyl)-3-phenyl-
  • 2-Propen-1-one,1-(4-bromophenyl)-3-phenyl-
  • N-(2,5-dimethyl-4-nitrophenyl)-2,2,2-trifluoroacetamide
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide